Insider Transactions in Q4 2025 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.36%
|
$300,000
$60.03 P/Share
|
|
Oct 15
2025
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+1.96%
|
$12,338
$62.8 P/Share
|
|
Oct 15
2025
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+0.45%
|
$20,956
$62.8 P/Share
|
|
Oct 15
2025
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+0.95%
|
$12,338
$62.8 P/Share
|
|
Oct 15
2025
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.32%
|
$6,138
$62.8 P/Share
|
|
Oct 07
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.4%
|
$120,000
$60.56 P/Share
|
|
Oct 07
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.38%
|
$20,000
$10.6 P/Share
|
|
Oct 06
2025
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
6,757
-40.86%
|
$405,420
$60.0 P/Share
|
|
Oct 01
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.34%
|
$275,000
$55.05 P/Share
|